Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
16.00
+1.20 (8.11%)
At close: May 6, 2026
Market Cap1.66B -0.6%
Revenue (ttm)431.04M +0.3%
Net Income42.40M -15.1%
EPS0.41 -14.8%
Shares Out103.81M
PE Ratio39.00
Forward PEn/a
Dividend0.11 (0.74%)
Ex-Dividend DateDec 17, 2025
Volume4,137,895
Average Volume954,040
Openn/a
Previous Close14.80
Day's Range14.80 - 16.10
52-Week Range11.10 - 18.50
Beta0.19
RSI67.91
Earnings DateApr 29, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 313
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILCOPHL
Full Company Profile

Financial Performance

In fiscal year 2025, Silco Pharmaceuticals's revenue was 431.54 million, an increase of 5.23% compared to the previous year's 410.10 million. Earnings were 42.65 million, a decrease of -7.04%.

Financial Statements